Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Study: Almost a third of people report lingering symptom 6-12 months after Covid-19
      Malaysiakini
      World
      Study: Almost a third of people report lingering symptom 6-12 months after Covid-19

      Study: Almost a third of people report lingering symptom 6-12 months after Covid-19

      Published: Mar 5, 2022 3:45 AM

      Almost a third of people report at least one ongoing symptom between six and 12 months after their coronavirus infection, a survey of 152,000 people in Denmark has found.

      The study includes one of the largest groups yet of people who were not hospitalised with Covid-19, and followed them for longer than other major studies, the researchers from Denmark's State Serum Institute (SSI) said.

      The questionnaire-based study suggested that... 

      Too early for China to seek 'coexistence' with Covid - govt expert

      Too early for China to seek 'coexistence' with Covid - govt expert

      Pfizer/BioNTech Covid vaccine less effective in ages 5-11 : New York study

      Pfizer/BioNTech Covid vaccine less effective in ages 5-11 : New York study

      China sticks with mRNA Covid-19 shot development amid uncertainties

      China sticks with mRNA Covid-19 shot development amid uncertainties

      Omicron BA.2 sub-variant more infectious but no more severe - Africa CDC

      Omicron BA.2 sub-variant more infectious but no more severe - Africa CDC

      Reinfections with Omicron subvariants are rare, Danish study finds

      Reinfections with Omicron subvariants are rare, Danish study finds

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      Too early for China to seek 'coexistence' with Covid - govt expert

      03-03-2022

      Pfizer/BioNTech Covid vaccine less effective in ages 5-11 : New York study

      01-03-2022

      China sticks with mRNA Covid-19 shot development amid uncertainties

      02-03-2022

      Omicron BA.2 sub-variant more infectious but no more severe - Africa CDC

      25-02-2022

      Reinfections with Omicron subvariants are rare, Danish study finds

      23-02-2022
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor